{"transactions":[{"id":4191014,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":172667,"kind":"person","name":"Maners Wendelin C","position":1,"cik":"0001490997","reported_name":"Maners Wendelin C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2017-10-05T16:11:30.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a monthly basis over the 24-month period immediately following the first anniversary of the grant date."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001534424-17-000415","document":"maners.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1490997/000153442417000415/maners.xml","form_type":"4"}},{"id":4191013,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":172667,"kind":"person","name":"Maners Wendelin C","position":1,"cik":"0001490997","reported_name":"Maners Wendelin C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2017-10-05T16:11:30.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest ratably in three equal installments on December 1, 2017, December 1, 2018 and December 1, 2019."}],"balance_after":1875,"derivative":{"exercise_price":2.6,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001534424-17-000415","document":"maners.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490997/000153442417000415/maners.xml","form_type":"4"}},{"id":4191012,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":172667,"kind":"person","name":"Maners Wendelin C","position":1,"cik":"0001490997","reported_name":"Maners Wendelin C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Marketing"}}],"security":"Common Stock","published_at":"2017-10-05T16:11:30.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":8503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received a portion of her 2016 cash bonus in the form of the Company's common stock based on the closing sales price of the Company's common stock on October 4, 2017.  The shares were granted under the Company's Second Amended and Restated 2013 Incentive Compensation Plan."}],"balance_after":38900,"source":{"system":"sec-edgar","filing":"0001534424-17-000415","document":"maners.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490997/000153442417000415/maners.xml","form_type":"4"}}]}